Core Scientific, Inc/tx Form 4 insider transactions

Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, sold 11,582 shares of common stock to satisfy tax obligations upon the vesting of restricted stock units.

Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, Inc., reports the acquisition of common stock through restricted stock units (RSUs) and performance-based RSUs (PSUs).

Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, sold 7,321 shares of common stock to satisfy tax obligations related to vesting restricted stock units.

Adam Sullivan, CEO of Core Scientific, reports the acquisition of common stock and grants of restricted stock units (RSUs) and performance-based RSUs (PSUs).

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, sold shares of common stock to satisfy tax obligations related to vesting restricted stock units.

Director Jarrod M Patten receives restricted stock units from Core Scientific, Inc.

Director Jordan Levy reports acquisition of restricted stock units in Core Scientific, Inc.

Director Todd A. Becker receives restricted stock units from Core Scientific, Inc.

Director Eric Stanton Weiss acquired 175,239 shares of Core Scientific, Inc. through restricted stock unit (RSU) grants.

Director Rozov Yadin reports acquisition of restricted stock units in Core Scientific, Inc.

Director Jeffrey David Booth receives restricted stock units from Core Scientific, Inc.

Director Rozov Yadin reports the acquisition of Tranche 2 Warrants in Core Scientific, Inc.

Core Scientific's CFO, Denise Brucia Sterling, sold 4,261 shares of common stock on May 13, 2024, to satisfy tax obligations related to vesting restricted stock units.

Director Jarrod M. Patten purchased 100,000 shares of Core Scientific, Inc. common stock at an average price of $3.3222 on March 15, 2024.

Director Todd A. Becker of Core Scientific, Inc. purchased 130,000 shares of common stock on March 15, 2024, at a weighted average price of $3.1551 per share.

Director Eric Stanton Weiss purchased 15,000 shares of Core Scientific, Inc. common stock at an average price of $3.0264 on March 15, 2024.

Core Scientific's CEO, Adam Taylor Sullivan, recently purchased 65,300 shares of the company's common stock at an average price of $3.0622 per share.

Director Rozov Yadin reports purchasing 80,000 shares of common stock and 90,000 Tranche 2 Warrants in Core Scientific, Inc./tx.